Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study on Capecitabine and Oxaliplatin for High-Risk Rectal Cancer Patients to Reduce Metastases

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Finland
  • Study of Durvalumab with Drug Combination for Patients with Locally Advanced Rectal Cancer

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    Spain
  • Study on Valproic Acid with Bevacizumab and Oxaliplatin/Fluoropyrimidine for Patients with RAS-Mutated Metastatic Colorectal Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Italy
  • Study on Atezolizumab for Patients with High-Risk Stage II or Stage III Colorectal Cancer Not Eligible for Oxaliplatin Chemotherapy

    Not recruiting

    2 1 1 1
    Germany
  • Study Comparing Short Course Radiotherapy and Chemoradiotherapy with Fluorouracil, Calcium Folinate, and Capecitabine for Intermediate and High-Risk Rectal Cancer Patients

    Not recruiting

    3 1 1 1
    Germany
  • Study on Capecitabine and Oxaliplatin for Patients with High Risk Rectal Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Italy
  • Study Comparing FOLFOX Before Surgery to Risk-Adapted Chemotherapy After Surgery for Patients with Locally Advanced Rectal Cancer and Low Risk of Local Failure

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Germany
  • Study on Induction Chemotherapy with Irinotecan, Folinic Acid, Fluorouracil, and Oxaliplatin for Patients with High-Risk Locally Advanced Rectal Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    The Netherlands
  • Study on Aspirin’s Effect on Recurrence and Survival in Patients with Non-Metastatic Breast, Colon, Rectal, Stomach, Esophageal, and Prostate Cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Ireland
  • Study on Chemotherapy and Pelvic Reirradiation for Patients with Recurrent Rectal Cancer Using Irinotecan, Levoleucovorin, Fluorouracil, Oxaliplatin, and Capecitabine

    Not recruiting

    3 1 1 1
    France